Undergraduate students from all disciplines are invited to submit a research abstract to the U of A's Undergraduate Research Symposium Poster Competition. Submissions are due by 11:59 p.m. Sunday, Feb ...
India Education Diary on MSN
IMRC 2025 concludes at IIMA with high-impact discussions, poster presentations, and diverse ...
The concluding day featured a conference-wide poster presentation session, where over 80 participants presented their research across diverse areas of management ...
Vice-Chancellor Prof. Ch. Satish Kumar underscored the global demand for innovation in artificial blood components, molecular ...
Abdulmalik Adetola Lawal received the Overall Best Research Poster Presentation Award in the B1 Master’s Students category at the University of Nevada, Reno.
P.D.A. College students win Best Poster Award at IIT Bombay, highlighting their growing research culture and academic ...
The Department of Energy’s Oak Ridge National Laboratory joined other national labs in hosting DOE Undersecretary of Science ...
Students in the WWAMI Medical Education Program at the University of Wyoming recently presented their summer research ...
Flatiron Health today announced its presence at the San Antonio Breast Cancer Symposium (SABCS) happening from December 9-12, 2025, in San Antonio, Texas. Flatiron's real-world data and research ...
Youngstown State University’s Sokolov Honors College recently hosted its second annual Pre-Health Research Symposium.
One of the three primary annual conferences in ML and AI research, NeurIPS 2025 is taking place Dec. 2-7 at the San Diego Convention Center.
The symposium will present new research, including significant trials like HER2CLIMB-05, LidERA, and DESTINY-Breast11, through various sessions. SABCS 2025 will spotlight new advances in breast cancer ...
Zacks Small Cap Research on MSN
RVPH: Brilaroxazine Poster Presentations
RVPH READ THE FULL RVPH RESEARCH REPORT Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 3Q:25 results, confirming the pre-new drug application (NDA) meeting with the FDA in 4Q:25 to see if ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈